Company intelligence
OncoDNA
About OncoDNA
OncoDNA is a Belgian theranostic company, founded in 2012, dedicated to helping laboratories, clinicians, and biopharma partners make better-informed decisions through advanced genomic insights. Our strength lies in our multi-dimensional expertise in centralised and decentralised solid tissue and liquid biopsy solutions underpinned by our bioinformatics and reporting software. OncoDNA supports customer to define their most effective testing strategy balancing the needs of the clinical context with local reimbursement arrangements. By combining advanced tissue and liquid molecular testing, bioinformatics, and interpretation tools, we deliver insights on cancer management from treatment selection to disease monitoring and management of disease recurrence. Our mission is to facilitate a personalized, evidence-based approach to creating treatment plans for oncology patients, ultimately improving cancer patients quality of life and outcomes. With a network of partner laboratories and distributors spanning Europe and beyond, OncoDNA ensures that wherever you are, you can access the tools and expertise needed to guide your care with confidence. Visit www.oncodna.com
Verified activity
Signals from OncoDNA
2 published signals
Presence & Recognition
OncoDNA will be on-site at ESMO from 23 to 27 October 2026 at Booth 1071 to walk participants through its latest diagnostic solutions and upcoming comprehensive genomic profiling.
Reported by OncoDNA
Products & Services
OncoDNA implemented the OncoDEEP® Kit for MVZ Pathologie Trier to streamline NGS pipeline operations and provide genomic coverage, HRR/HRD assessment, and clinical insights for solid tumours.
Reported by OncoDNA